About - EW :

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Employees - 15800, CEO - Bernard J. Zovighian, Sector - Healthcare, Country - US, Market Cap -

Altman ZScore(max is 10): 12.71, Piotroski Score(max is 10): 6, Working Capital: $4819700000, Total Assets: $13321200000, Retained Earnings: $14621200000, EBIT: 1259900000, Total Liabilities: $2993700000, Revenue: $6303500000

AryaFin Target Price - $47.26 - Current Price $ - Analyst Target Price $

Stats & Key Metrics
TickerEW
Index
Curent Price
Change
Market Cap
Average Volume
Income
Sales
Book Value/Share
Cash/Share
Dividend Est
Dividend TTM
Dividend Ex-Date
Employees
Moving Avg 20days
Moving Avg 50days
Moving Avg 200days
Shares Outstanding
Earnings Date
Inst. Ownership
Key Ratios & Margins
Price/Earnings
Forwad P/E
PE Growth
Price/Sales
Price/Book
Price/Cash
Price/FCF
Quick Ratio
Current Ratio
Debt/Equity
Return on Assets
Return on Equity
Return on Investment
Gross Margin
Ops Margin
Profit Margin
RSI
BETA(β)
From 52week Low
From 52week High
Earnings & Valuation
EPS
EPS next Year
EPS next Qtr
EPS this Year
EPS next 5 Year
EPS past 5 Year
Sales past 5 Year
EPS Y/Y
Sales Y/Y
EPS Q/Q
Sales Q/Q
Sales Surprise
EPS Surprise
ATR(14)
Perf Week
Perf Month
Perf Quarter
Perf Year
Perf YTD
Target Price

AryaFin Engine© - An AI FinTech Venture - 2024-26 Disclaimer